Areas Of Expertise:

• Head and Neck Oncology

• Oral and Maxillofacial Surgery

Education & Training:

• MDS (Oral and Maxillofacial Surgery) – Terna Dental College and Hospital, Navi Mumbai

• Fellowship (Surgical Oncology) – Tata Memorial Hospital, Mumbai

• BDS – MGM Dental College and Hospital, Navi Mumbai

Awards and Accolades:

• Ranked 3rd in 2nd year B.D.S. University Examination

• Subject Topper, Preclinical Conservative Dentistry, 2ndyear B.D.S. University Examination

Memberships:

• Multinational Association of Supportive Care in Cancer (MASCC)

• Indian Society of Oncology

• Foundation for Head Neck Oncology (FHNO)

• American Society of Clinical Oncology (ASCO)

• International Bone Research Association (IBRA)

• Association of Oral & Maxillofacial Surgery India (AOMSI)

• International Association of Oral & Maxillofacial Surgery (IAOMS)

• AO-CMF

Academics & Research:

• Thiagarajan S, Rukmangathan T, Sharma D, Kakade A, et al. Prevalence, risk factors, and quality of life in patients with head and neck lymphedema following treatment for head and neck cancer: The HeNLy-1 study. Oral Oncol. 2026;173:107838.

• Kakade AN, Joshi SS, Naik CS, Mhatre BV, Ansari A. Clinical efficacy of 0.75% ropivacaine vs. 2% lignocaine hydrochloride with adrenaline (1:80,000) in patients undergoing removal of bilateral maxillary third molars: a randomized controlled trial. J Dent Anesth Pain Med. 2021;21(5).

• Contributing researcher, MASCC clinical practice guidelines for the prevention and management of diarrhea induced by oral targeted agents – presented at the MASCC/ISOO Annual Meeting 2026

• Research Fellow, multicenter phase III randomized controlled trial evaluating neoadjuvant chemotherapy in mandible preservation in oral cavity cancers, Tata Memorial Hospital (2022 – 2024)

• Research: “Cell adhesion and actin-associated proteins improve prognostic stratification in oral squamous cell carcinoma: A large Indian cohort study” (submitted for publication)

• Research: “Evaluating expenditure and financial support for economically vulnerable patients with head and neck squamous cell carcinoma in a tertiary centre” (submitted for publication)